Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 31-40 of 2904 for cancer

Edit search filters
  1. Virtual Dignity Therapy For Palliative Care Patients With Advanced Cancer

    Rochester, MN

  2. Study Of AB598 Monotherapy And Combination Therapy In Participants With Advanced Cancers

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  3. Vaccine Therapy Plus Pembrolizumab In Treating Advanced Ovarian, Fallopian Tube, Or Primary Peritoneal Cavity Cancer (FRAPPE)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  4. A Study Of NB003 In Patients With Advanced Malignancies

    Jacksonville, FL

  5. A Study Of PF-08052666/​SGN-MesoC2 In Advanced Solid Tumors

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  6. Dose Optimization And Expansion Study Of DFV890 In Adult Patients With Myeloid Diseases

    Rochester, MN

  7. A Study Of ART0380 For The Treatment Of Advanced Or Metastatic Solid Tumors

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  8. A First-in-Human (FIH) Study To Evaluate The Safety And Tolerability Of VVD-130037 In Participants With Advanced Solid Tumors

    Jacksonville, FL, Rochester, MN

  9. A Study Of PARG Inhibitor ETX-19477 In Patients With Advanced Solid Malignancies

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  10. Risk Stratified De-escalated De-intensified Treatment For High Risk Prostate Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer